These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

564 related articles for article (PubMed ID: 27039035)

  • 1. Inhibition of alpha oscillations through serotonin-2A receptor activation underlies the visual effects of ayahuasca in humans.
    Valle M; Maqueda AE; Rabella M; Rodríguez-Pujadas A; Antonijoan RM; Romero S; Alonso JF; Mañanas MÀ; Barker S; Friedlander P; Feilding A; Riba J
    Eur Neuropsychopharmacol; 2016 Jul; 26(7):1161-75. PubMed ID: 27039035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the South American psychoactive beverage ayahuasca on regional brain electrical activity in humans: a functional neuroimaging study using low-resolution electromagnetic tomography.
    Riba J; Anderer P; Jané F; Saletu B; Barbanoj MJ
    Neuropsychobiology; 2004; 50(1):89-101. PubMed ID: 15179026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autonomic, neuroendocrine, and immunological effects of ayahuasca: a comparative study with d-amphetamine.
    Dos Santos RG; Valle M; Bouso JC; Nomdedéu JF; Rodríguez-Espinosa J; McIlhenny EH; Barker SA; Barbanoj MJ; Riba J
    J Clin Psychopharmacol; 2011 Dec; 31(6):717-26. PubMed ID: 22005052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topographic pharmaco-EEG mapping of the effects of the South American psychoactive beverage ayahuasca in healthy volunteers.
    Riba J; Anderer P; Morte A; Urbano G; Jané F; Saletu B; Barbanoj MJ
    Br J Clin Pharmacol; 2002 Jun; 53(6):613-28. PubMed ID: 12047486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human pharmacology of ayahuasca: subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics.
    Riba J; Valle M; Urbano G; Yritia M; Morte A; Barbanoj MJ
    J Pharmacol Exp Ther; 2003 Jul; 306(1):73-83. PubMed ID: 12660312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism and disposition of N,N-dimethyltryptamine and harmala alkaloids after oral administration of ayahuasca.
    Riba J; McIlhenny EH; Valle M; Bouso JC; Barker SA
    Drug Test Anal; 2012; 4(7-8):610-6. PubMed ID: 22514127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of serotonin 2A receptors underlies the psilocybin-induced effects on α oscillations, N170 visual-evoked potentials, and visual hallucinations.
    Kometer M; Schmidt A; Jäncke L; Vollenweider FX
    J Neurosci; 2013 Jun; 33(25):10544-51. PubMed ID: 23785166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of ayahuasca on sensory and sensorimotor gating in humans as measured by P50 suppression and prepulse inhibition of the startle reflex, respectively.
    Riba J; Rodríguez-Fornells A; Barbanoj MJ
    Psychopharmacology (Berl); 2002 Dec; 165(1):18-28. PubMed ID: 12474114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naltrexone but Not Ketanserin Antagonizes the Subjective, Cardiovascular, and Neuroendocrine Effects of Salvinorin-A in Humans.
    Maqueda AE; Valle M; Addy PH; Antonijoan RM; Puntes M; Coimbra J; Ballester MR; Garrido M; González M; Claramunt J; Barker S; Lomnicka I; Waguespack M; Johnson MW; Griffiths RR; Riba J
    Int J Neuropsychopharmacol; 2016 Jul; 19(7):. PubMed ID: 26874330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacology of ayahuasca administered in two repeated doses.
    Dos Santos RG; Grasa E; Valle M; Ballester MR; Bouso JC; Nomdedéu JF; Homs R; Barbanoj MJ; Riba J
    Psychopharmacology (Berl); 2012 Feb; 219(4):1039-53. PubMed ID: 21842159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ayahuasca: Psychological and Physiologic Effects, Pharmacology and Potential Uses in Addiction and Mental Illness.
    Hamill J; Hallak J; Dursun SM; Baker G
    Curr Neuropharmacol; 2019; 17(2):108-128. PubMed ID: 29366418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased frontal and paralimbic activation following ayahuasca, the pan-Amazonian inebriant.
    Riba J; Romero S; Grasa E; Mena E; Carrió I; Barbanoj MJ
    Psychopharmacology (Berl); 2006 May; 186(1):93-8. PubMed ID: 16575552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ayahuasca enhances creative divergent thinking while decreasing conventional convergent thinking.
    Kuypers KP; Riba J; de la Fuente Revenga M; Barker S; Theunissen EL; Ramaekers JG
    Psychopharmacology (Berl); 2016 Sep; 233(18):3395-403. PubMed ID: 27435062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonergic psychedelics temporarily modify information transfer in humans.
    Alonso JF; Romero S; Mañanas MÀ; Riba J
    Int J Neuropsychopharmacol; 2015 Mar; 18(8):. PubMed ID: 25820842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Daytime Ayahuasca administration modulates REM and slow-wave sleep in healthy volunteers.
    Barbanoj MJ; Riba J; Clos S; Giménez S; Grasa E; Romero S
    Psychopharmacology (Berl); 2008 Feb; 196(2):315-26. PubMed ID: 18030450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ayahuasca: Pharmacology, neuroscience and therapeutic potential.
    Domínguez-Clavé E; Soler J; Elices M; Pascual JC; Álvarez E; de la Fuente Revenga M; Friedlander P; Feilding A; Riba J
    Brain Res Bull; 2016 Sep; 126(Pt 1):89-101. PubMed ID: 26976063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicokinetics and Toxicodynamics of Ayahuasca Alkaloids
    Brito-da-Costa AM; Dias-da-Silva D; Gomes NGM; Dinis-Oliveira RJ; Madureira-Carvalho Á
    Pharmaceuticals (Basel); 2020 Oct; 13(11):. PubMed ID: 33114119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurobiological research on N,N-dimethyltryptamine (DMT) and its potentiation by monoamine oxidase (MAO) inhibition: from ayahuasca to synthetic combinations of DMT and MAO inhibitors.
    Egger K; Aicher HD; Cumming P; Scheidegger M
    Cell Mol Life Sci; 2024 Sep; 81(1):395. PubMed ID: 39254764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the therapeutic potential of Ayahuasca: acute intake increases mindfulness-related capacities.
    Soler J; Elices M; Franquesa A; Barker S; Friedlander P; Feilding A; Pascual JC; Riba J
    Psychopharmacology (Berl); 2016 Mar; 233(5):823-9. PubMed ID: 26612618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoamine oxidase inhibitors in South American hallucinogenic plants: tryptamine and beta-carboline constituents of ayahuasca.
    McKenna DJ; Towers GH; Abbott F
    J Ethnopharmacol; 1984 Apr; 10(2):195-223. PubMed ID: 6587171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.